Analysts’ ratings for Harmony Biosciences Hldgs (NASDAQ: HRMY) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Latest Ratings for HRMY
DateFirmActionFromTo Dec 2021OppenheimerInitiates Coverage OnOutperform Nov 2021Raymond JamesInitiates Coverage OnOutperform Sep 2021NeedhamInitiates Coverage OnBuy